US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist

2.0100
0.00000.00%

Close Nov 22 16:00 ET

3.84MMarket Cap-176P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

1,513.04%2.6M

213.11%4.92M

-61.22%3.19M

-73.42%1.78M

-25.81%161K

76.52%1.57M

349.32%8.24M

78.26%6.71M

-Cash and cash equivalents

1,513.04%2.6M

213.11%4.92M

-61.22%3.19M

-73.42%1.78M

-25.81%161K

76.52%1.57M

349.32%8.24M

78.26%6.71M

Receivables

----

--13K

--26K

--13K

----

-Related party accounts receivable

----

--13K

--26K

--13K

----

Current deferred assets

----

-8.28%310K

----

Other current assets

55.56%28K

0.00%69K

-41.41%116K

-51.09%67K

-10.00%18K

-40.00%69K

60.98%198K

28.04%137K

Total current assets

422.91%2.63M

199.40%4.99M

-60.81%3.31M

-72.97%1.85M

-12.70%502K

65.77%1.67M

331.85%8.45M

72.85%6.85M

Non current assets

Related parties assets

----

--13K

--26K

--13K

----

Total non current assets

--0

Total assets

422.91%2.63M

199.40%4.99M

-60.81%3.31M

-72.97%1.85M

-12.70%502K

65.77%1.67M

331.85%8.45M

72.85%6.85M

Liabilities

Current liabilities

Payables

17.32%657K

18.40%592K

77.01%662K

167.33%401K

38.27%560K

65.02%500K

-31.25%374K

-58.56%150K

-accounts payable

-52.70%140K

-56.95%192K

-6.06%310K

-39.53%78K

-18.68%296K

52.22%446K

-33.06%330K

-57.57%129K

-Due to related parties current

95.83%517K

640.74%400K

700.00%352K

1,438.10%323K

543.90%264K

440.00%54K

-13.73%44K

-63.79%21K

Current accrued expenses

-73.45%248K

-73.56%340K

-94.24%243K

-68.12%198K

684.87%934K

1,344.94%1.29M

1,929.33%4.22M

404.88%621K

Other current liabilities

-99.12%29K

-99.20%47K

-92.78%413K

-77.54%586K

--3.3M

--5.87M

--5.72M

--2.61M

Current liabilities

-80.63%973K

-85.14%1.16M

-86.68%1.41M

-66.58%1.2M

718.24%5.02M

1,819.41%7.81M

1,230.49%10.6M

603.14%3.58M

Non current liabilities

Total non current liabilities

--0

Total liabilities

-80.63%973K

-85.14%1.16M

-86.68%1.41M

-66.58%1.2M

718.24%5.02M

1,819.41%7.81M

1,230.49%10.6M

603.14%3.58M

Shareholders'equity

Share capital

--0

--3K

--1K

-50.00%1K

--0

-common stock

--0

--3K

--1K

-50.00%1K

--0

-Preferred stock

--0

Retained earnings

-10.34%-101.04M

-6.37%-97.96M

-8.15%-95.27M

-12.88%-90.93M

-12.87%-91.57M

-14.45%-92.09M

-10.30%-88.09M

-4.61%-80.55M

Paid-in capital

17.89%103.65M

18.40%102.72M

13.24%98.1M

9.53%92.51M

8.42%87.92M

7.03%86.76M

6.93%86.63M

4.98%84.46M

Total stockholders'equity

171.51%2.61M

189.28%4.76M

295.32%2.84M

-59.49%1.58M

-9,258.97%-3.65M

-992.31%-5.34M

-225.28%-1.45M

13.16%3.91M

Noncontrolling interests

-9.86%-958K

-15.68%-937K

-33.05%-938K

-45.23%-928K

---872K

---810K

---705K

---639K

Total equity

136.53%1.65M

162.27%3.83M

187.99%1.9M

-79.98%654K

-11,494.87%-4.52M

-1,127.76%-6.15M

-286.11%-2.16M

-5.36%3.27M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	1,513.04%2.6M	213.11%4.92M	-61.22%3.19M	-73.42%1.78M	-73.42%1.78M	-25.81%161K	76.52%1.57M	349.32%8.24M	78.26%6.71M	78.26%6.71M
-Cash and cash equivalents	1,513.04%2.6M	213.11%4.92M	-61.22%3.19M	-73.42%1.78M	-73.42%1.78M	-25.81%161K	76.52%1.57M	349.32%8.24M	78.26%6.71M	78.26%6.71M
Receivables	----	----	----	----	----	--13K	--26K	--13K	----	----
-Related party accounts receivable	----	----	----	----	----	--13K	--26K	--13K	----	----
Current deferred assets	----	----	----	----	----	-8.28%310K	----	----	----	----
Other current assets	55.56%28K	0.00%69K	-41.41%116K	-51.09%67K	-51.09%67K	-10.00%18K	-40.00%69K	60.98%198K	28.04%137K	28.04%137K
Total current assets	422.91%2.63M	199.40%4.99M	-60.81%3.31M	-72.97%1.85M	-72.97%1.85M	-12.70%502K	65.77%1.67M	331.85%8.45M	72.85%6.85M	72.85%6.85M
Non current assets
Related parties assets	----	----	----	----	----	--13K	--26K	--13K	----	----
Total non current assets	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	422.91%2.63M	199.40%4.99M	-60.81%3.31M	-72.97%1.85M	-72.97%1.85M	-12.70%502K	65.77%1.67M	331.85%8.45M	72.85%6.85M	72.85%6.85M
Liabilities
Current liabilities
Payables	17.32%657K	18.40%592K	77.01%662K	167.33%401K	167.33%401K	38.27%560K	65.02%500K	-31.25%374K	-58.56%150K	-58.56%150K
-accounts payable	-52.70%140K	-56.95%192K	-6.06%310K	-39.53%78K	-39.53%78K	-18.68%296K	52.22%446K	-33.06%330K	-57.57%129K	-57.57%129K
-Due to related parties current	95.83%517K	640.74%400K	700.00%352K	1,438.10%323K	1,438.10%323K	543.90%264K	440.00%54K	-13.73%44K	-63.79%21K	-63.79%21K
Current accrued expenses	-73.45%248K	-73.56%340K	-94.24%243K	-68.12%198K	-68.12%198K	684.87%934K	1,344.94%1.29M	1,929.33%4.22M	404.88%621K	404.88%621K
Other current liabilities	-99.12%29K	-99.20%47K	-92.78%413K	-77.54%586K	-77.54%586K	--3.3M	--5.87M	--5.72M	--2.61M	--2.61M
Current liabilities	-80.63%973K	-85.14%1.16M	-86.68%1.41M	-66.58%1.2M	-66.58%1.2M	718.24%5.02M	1,819.41%7.81M	1,230.49%10.6M	603.14%3.58M	603.14%3.58M
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	-80.63%973K	-85.14%1.16M	-86.68%1.41M	-66.58%1.2M	-66.58%1.2M	718.24%5.02M	1,819.41%7.81M	1,230.49%10.6M	603.14%3.58M	603.14%3.58M
Shareholders'equity
Share capital	--0	--0	--0	--3K	--3K	--1K	-50.00%1K	-50.00%1K	--0	--0
-common stock	--0	--0	--0	--3K	--3K	--1K	-50.00%1K	-50.00%1K	--0	--0
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-10.34%-101.04M	-6.37%-97.96M	-8.15%-95.27M	-12.88%-90.93M	-12.88%-90.93M	-12.87%-91.57M	-14.45%-92.09M	-10.30%-88.09M	-4.61%-80.55M	-4.61%-80.55M
Paid-in capital	17.89%103.65M	18.40%102.72M	13.24%98.1M	9.53%92.51M	9.53%92.51M	8.42%87.92M	7.03%86.76M	6.93%86.63M	4.98%84.46M	4.98%84.46M
Total stockholders'equity	171.51%2.61M	189.28%4.76M	295.32%2.84M	-59.49%1.58M	-59.49%1.58M	-9,258.97%-3.65M	-992.31%-5.34M	-225.28%-1.45M	13.16%3.91M	13.16%3.91M
Noncontrolling interests	-9.86%-958K	-15.68%-937K	-33.05%-938K	-45.23%-928K	-45.23%-928K	---872K	---810K	---705K	---639K	---639K
Total equity	136.53%1.65M	162.27%3.83M	187.99%1.9M	-79.98%654K	-79.98%654K	-11,494.87%-4.52M	-1,127.76%-6.15M	-286.11%-2.16M	-5.36%3.27M	-5.36%3.27M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data